U.S. health officials met with with Walmart (WMT), Amazon (AMZN), and other retailers last week as part of an effort to help Americans get their medicines more directly from companies that make them, Rachel Cohrs Zhang and Jaewon Kang of Bloomberg report. The conversations between the Trump administration and experts from the straight-to-consumer drug industry are intended to explore streamlining the way Americans get their medicines and therefore lower costs, and while officials at the U.S. Department of Health and Human Services conducted the meeting to discuss options, it is unclear what approach and timeline the department might pursue. Walmart started offering prescription delivery in October, making it a competitor to Amazon, which runs a pharmacy division that offers same-day drug delivery in some locations, and has also partnered with Eli Lilly (LLY) to sell weight loss drugs directly to patients.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WMT:
- Nvidia, Alphabet, Broadcom, Walmart, and CrowdStrike: Major Stock Sell-Offs Unveiled!
- Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
- Walmart Stock (WMT) Beefs Up as New Meat Factory Boosts Transparency
- Walmart opens first owned beef processing facility in Kansas
- Walmart’s Big Insider Trade! Founding Walton Family Sells $329M of WMT Stock